Winton Group LTD Concert Pharmaceuticals, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$3.17 - $4.15 $40,094 - $52,489	-12,648 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$3.77 - $5.24 $2,069 - $2,876	549 Added 4.54%	12,648 $53,000
Q1 2021 Jul 21, 2021	BUY	$4.86 - $13.07 $58,801 - $158,133	12,099 New	12,099 $60,000
Q4 2020 Feb 12, 2021	SELL	$9.48 - $12.84 $298,676 - $404,537	-31,506 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$8.67 - $10.82 $242,820 - $303,035	-28,007 Reduced 47.06%	31,506 $309,000
Q2 2020 Aug 05, 2020	SELL	$7.8 - $11.52 $8,829 - $13,040	-1,132 Reduced 1.87%	59,513 $592,000
Q1 2020 May 11, 2020	SELL	$5.98 - $13.09 $167,780 - $367,266	-28,057 Reduced 31.63%	60,645 $536,000
Q4 2019 Feb 13, 2020	BUY	$5.71 - $9.22 $350,177 - $565,434	61,327 Added 224.03%	88,702 $818,000
Q3 2019 Nov 08, 2019	BUY	$5.88 - $12.35 $160,965 - $338,081	27,375 New	27,375 $161,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.